Sustained delivery of captopril from floating matrix tablets.
about
Swelling/floating capability and drug release characterizations of gastroretentive drug delivery system based on a combination of hydroxyethyl cellulose and sodium carboxymethyl celluloseNew formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.Novel swellable polymer of orchidaceae family for gastroretentive drug delivery of famotidineStatus of novel drug delivery technology for phytotherapeutics.Drug release kinetics and physicochemical characteristics of floating drug delivery systems.Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration.Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups.Lornoxicam gastro retentive floating matrix tablets: Design and in vitro evaluationDesign and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug.Formulation optimization of hydrodynamically balanced oral controlled release bioadhesive tablets of tramadol hydrochloride.Development, characterization and permeability assessment based on caco-2 monolayers of self-microemulsifying floating tablets of tetrahydrocurcuminApplication of design of experiment for floating drug delivery of tapentadol hydrochloride.Preparation and in vitro-in vivo evaluation of acyclovir floating tablets.Effect of antioxidants on captopril floating matrices.Study of controlled-release floating tablets of dipyridamole using the dry-coated method.pH responsive alginate polymeric rafts for controlled drug release by using box behnken response surface design.Effects of Formulation and Process Variables on Gastroretentive Floating Tablets with A High-Dose Soluble Drug and Experimental Design Approach
P2860
Q28543089-3664DB94-1071-4BE1-B236-3E13F96F38BEQ33947936-1631C0D3-0BF0-471A-B9E8-21C5D2BB20B7Q34201752-590EC173-2ABA-436E-993E-B8495FB1EF84Q37510870-BD89C0AC-53DA-4DEE-B79A-AD1662A7698AQ37867128-1C1353DB-30E4-490D-9026-9EFCEFCF22ADQ38003472-1EA990DF-C75B-474E-80FD-C6851145BEEEQ38247096-9B54262B-C69E-4007-971C-D592F3AA7371Q39151842-4E3F0404-63D2-42E7-B963-6AB0DB0D8C03Q39285643-CCA1D33D-58E7-4AD1-8214-50F267BFACB3Q41182114-6C8D1D48-F926-41F3-83C4-7BBEB5123367Q41988058-EF11EE69-27EB-47FC-A32A-FCC96CA35889Q42233637-03CC42ED-C491-4087-809D-D17C79B09A4CQ42292445-DFDEBD51-43AA-452B-8BF6-E4F8B7BD3750Q42717378-896C398B-D738-4676-AFE6-89551782F415Q47909177-AA5C2B4A-6330-4FD2-9981-93C144254726Q55387595-730D227E-73C9-4E60-A4B2-8356182D2FFEQ58730462-1860BD5E-FB3E-4C86-81F1-439BC4965AB7
P2860
Sustained delivery of captopril from floating matrix tablets.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Sustained delivery of captopril from floating matrix tablets.
@en
Sustained delivery of captopril from floating matrix tablets.
@nl
type
label
Sustained delivery of captopril from floating matrix tablets.
@en
Sustained delivery of captopril from floating matrix tablets.
@nl
prefLabel
Sustained delivery of captopril from floating matrix tablets.
@en
Sustained delivery of captopril from floating matrix tablets.
@nl
P1476
Sustained delivery of captopril from floating matrix tablets
@en
P2093
Inéz Jiménez-Martínez
Leopoldo Villafuerte-Robles
P356
10.1016/J.IJPHARM.2008.05.040
P407
P577
2008-06-07T00:00:00Z